The short answer
Graf published an update on delta sleep-inducing peptide in Peptides in 1986, nine years after the original report. Reviews written mid-literature are useful because they record what the field expected next.
Key facts
- Review
- Graf 1986 (PMID 3550726)
- Journal
- Peptides, Nov-Dec 1986
- Years after discovery
- Nine
- Author
- Also co-author of the 1984 tissue work
- Value of mid-literature reviews
- They record expectations
- What followed
- No gene, no receptor
Why a nine-year update is a useful document
A review written at the point where a field still expects resolution captures something later accounts cannot. It records what was thought to be nearly settled and what was expected imminently. Comparing that against what actually followed is a direct measure of how a research programme went.
Where the field stood at that point
The sequence was known, synthesis was routine, immunoassays existed, and distribution had been mapped across brain and peripheral tissue. That is a substantial platform, and by the ordinary progression it should have been followed by receptor identification and then a gene. Neither arrived.
Research material referenced
DSIP 5mg, third-party HPLC tested
What the same author had already reported
Graf was a co-author of the 1984 work showing that peripheral immunoreactive material was mostly larger than DSIP. So the complication was known to the person writing the update. This was not a field unaware of its own difficulties, a point to keep in mind given how often the sceptical case is presented as hindsight.
Why the receptor never arriving is decisive
A receptor gives a field binding assays, dose-response relationships, selective antagonists and a target. Without one, an observed effect cannot be attributed to a pathway, and forty further years of work has not supplied it. This site makes the same point about MOTS-c, Selank and Semax, and DSIP is the longest-running instance.
How to read old reviews generally
As evidence about the state of a field at a date, not as current summaries. A 1986 review is accurate about 1986. Citing it as though it described the present position, which happens with compounds whose literature peaked decades ago, misrepresents both the review and the field.
Regulatory position
DSIP holds no marketing authorisation anywhere, and no claim is made here about sleep or any condition in any person. Material supplied is for laboratory research only.
Frequently asked questions
Why read a 1986 review?
It records what the field expected next, which can be compared against what actually followed: a direct measure of how the programme went.
Was the field aware of the immunoassay problem?
Yes. Graf co-authored the 1984 work showing peripheral immunoreactive material was mostly larger than DSIP.
What never arrived?
A receptor and a gene. Without a receptor there is no way to attribute an observed effect to a pathway.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedGraf MV, Delta-sleep-inducing peptide (DSIP): an update. Peptides 1986 (PMID 3550726)pubmed.ncbi.nlm.nih.gov
- PubMedGraf MV, Kastin AJ. Proc Soc Exp Biol Med 1984 (PMID 6548030)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More DSIP (Delta Sleep-Inducing Peptide) articles
- The Barrier Any Central Claim Has to CrossA compound said to act on sleep must reach the brain. The blood-brain barrier excludes most peptides, and getting across is an engineering problem.
- What Is DSIP? The Nonapeptide Named for an EEG EffectDSIP is a nonapeptide isolated from rabbit blood in 1977 and named for an observed EEG effect. No gene, precursor or receptor has ever been identified.
- Does DSIP Actually Induce Sleep? What the Evidence ShowsDSIP is named for a sleep effect. The evidence has never firmed up: no gene, no receptor, and a literature its own reviewers call an unresolved riddle.
- How DSIP Was DiscoveredSchoenenberger and Monnier stimulated a sleeping rabbit's thalamus, collected the blood draining from its brain and isolated a peptide. The 1977 method.
- The Missing Biology: No Gene, No Precursor, No ReceptorFor an endogenous signalling peptide, DSIP is missing all three of the things that normally establish one. Why that absence matters more than any single study.